Durability of response to dapagliflozin: a review of long-term efficacy and safety.

CONCLUSIONS: The findings across the studies support the use of dapagliflozin for the long-term treatment of T2D across a broad spectrum of patients.
PMID: 28699798 [PubMed - as supplied by publisher]

Source: Current Medical Research and Opinion - July 14, 2017 Category: Research Tags: Curr Med Res Opin Source Type: research